The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin (Q77172536)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1998

Language	Label	Description	Also known as
English	The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin	scientific article published on 01 July 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

based on heuristic

inferred from title

8

object named as

R W Henley

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

M J Koren

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D G Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D B Hunninghake

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

M H Davidson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J M McKenney

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S R Weiss

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

H G Schrott

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P Tresh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R W McLain

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R G Bakker-Arkema

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D M Black

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

59-70

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10182195%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

https://scigraph.springernature.com/pub.10.2165/00019053-199814010-00006

0 references

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin--a new lipid-lowering drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 4S study and its pharmacoeconomic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10182195

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77172536&oldid=2150597376"